Back to Journals » Clinical Ophthalmology » Volume 18

Prevalence and Distribution of Macular Fluid with Central Retinal Artery Occlusion and Anterior Ischaemic Optic Neuropathy [Response to Letter]

Authors Fouad YA , Hamza MN, Wessam MM

Received 11 June 2024

Accepted for publication 14 June 2024

Published 19 June 2024 Volume 2024:18 Pages 1745—1747

DOI https://doi.org/10.2147/OPTH.S482249



Yousef A Fouad, Mohamed Nabil Hamza, Moataz M Wessam

Department of Ophthalmology, Ain Shams University Hospitals, Cairo, Egypt

Correspondence: Yousef A Fouad, Ophthalmology Department, Ain Shams University, Ramses street, Abbassiya, Cairo, 11517, Egypt, Tel +201063781237, Email [email protected]


View the original paper by Dr Fouad and colleagues

This is in response to the Letter to the Editor


Dear editor

We thank Plant et al for their interest in our article “Prevalence and Distribution of Macular Fluid with Central Retinal Artery Occlusion and Anterior Ischemic Optic Neuropathy”.1 In our study, 6 out of 11 eyes with acute non-arteritic anterior ischemic optic neuropathy (AION) had intraretinal fluid on optical coherence tomography (OCT). All 6 eyes had fluid involving the outer nuclear layer, 4 eyes had fluid within the inner nuclear layer (INL), and 3 eyes had fluid within the ganglion cell layer (GCL).

We agree with the authors of the letter on the importance of distinguishing the acutely developing microcystic macular edema from the later developing cystic degeneration of the INL (referred to as “retrograde maculopathy”). In a prior article by the authors,2 it was hypothesized that the former develops due to “axonal swelling and further vascular compromise” that leads to “leakage of the peripapillary vessels” saturating Müller cell capacity to remove fluid. To support their hypothesis, the authors cited a study3 that quantified INL cells across the retina and suggested that the decrease in Müller cell density with eccentricity from the fovea explains why fluid is observed in the peripapillary area and not the fovea in eyes with AION. It is important to note that the cited article by Masri and colleagues3 actually found the peak Müller cell density to be at 0.8 mm eccentricity from the fovea, with lower density noted in the central fovea and peripheral macula, and with a higher proportion of Müller cells in the peripheral compared to the central retina. Further, the overwhelmed Müller cells by the leakage from the peripapillary vessels would not explain why in some instances fluid cysts could be noted within the GCL even away from the peripapillary region (an example from our cohort is given in Figure 1).

Figure 1 Optical coherence tomography scans depicting different distribution of intraretinal fluid in an eye with acute anterior ischemic optic neuropathy. A horizontal macular radial scan (lower B-scan) shows peripapillary accumulation of fluid within the outer and inner nuclear layers and a swollen optic disc. An oblique macular radial scan (upper B-scan) shows cystic cavities within the ganglion cell layer in the upper nasal parafovea.

The authors of the letter also address the description of central retinal artery occlusion (CRAO) cases included in our study. They suggest that the term “cloudy swelling” should be used instead of whitening when describing the colored fundus photographs of CRAO cases, and that the term also serves the OCT appearance of the GCL in such cases. We would like to point out that CRAO has different grades and may evolve over time.4 For example, paracentral acute middle maculopathy with INL infarcts and without GCL involvement may present as greyish-white lesions within the macula and can be the sole presentation in milder cases of CRAO.5 That is why we believe that not all cases of CRAO involve cloudy swelling of the GCL (although the case depicted in our article had full-blown CRAO and did indeed show cloudy swelling). It is also important to distinguish between increased macular thickness with CRAO due to swelling of the inner retinal layers6 from actual cystic fluid accumulation within the middle and outer retinal layers.7 While the former does represent tissue edema (cytotoxic edema) as the authors accurately point out, the latter may evolve during the disease course7 and could possibly have a different pathophysiological mechanism of Müller cell dysfunction. Again, we thank the authors for their interest in our article, congratulate them on their prior studies and look forward to their future work on this important topic.

Funding

There is no funding to report.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Fouad Y, Hamza M, Wessam M. Prevalence and distribution of macular fluid with central retinal artery occlusion and anterior ischemic optic neuropathy. Clin Ophthalmol. 2024;18:887–893. doi:10.2147/OPTH.S457503

2. Chapelle A-C, Rakic J-M, Plant GT. The occurrence of intraretinal and subretinal fluid in anterior ischemic optic neuropathy. Ophthalmology. 2023;130:1191–1200. doi:10.1016/j.ophtha.2023.07.015

3. Masri RA, Weltzien F, Purushothuman S, et al. Composition of the inner nuclear layer in human retina. Invest Ophthalmol Vis Sci. 2021;62:22. doi:10.1167/iovs.62.9.22

4. Chen C, Singh G, Madike R, Cugati S. Central retinal artery occlusion: a stroke of the eye. Eye. 2024. doi:10.1038/s41433-024-03029-w

5. Scharf J, Freund KB, Sadda S, Sarraf D. Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses. Prog Retin Eye Res. 2021;81:100884. doi:10.1016/j.preteyeres.2020.100884

6. Shinoda K, Yamada K, Matsumoto CS, et al. Changes in retinal thickness are correlated with alterations of electroretinogram in eyes with central retinal artery occlusion. Graefe’s Arch Clin Exp Ophthalmol. 2008;246:949–954. doi:10.1007/s00417-008-0791-x

7. Estawro R, Abraham N, Fouad Y, et al. Cystoid macular edema as a complication of central retinal artery occlusion. Am J Ophthalmol Case Reports. 2024;33:101998. doi:10.1016/j.ajoc.2024.101998

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.